Overview
- 32 FDA inspections are on record.
- 17 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-03-10.
At a glance
Inspections
32
Form 483s
17
EIRs
16
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 2 Mar 2026 – 10 Mar 2026 | Human Drugs | 483 | On file |
| 8 Jan 2025 – 17 Jan 2025 | Human Drugs | 483 | View 483 → |
| 21 Mar 2024 – 27 Mar 2024 | Biologics | Clean | |
| 26 Jun 2023 – 30 Jun 2023 | Human Drugs | 483 | On file |
| 30 Aug 2021 – 3 Sep 2021 | Biologics | Clean | |
| 9 Dec 2019 – 17 Jan 2020 | Human Drugs | 483 | View 483 → |
| 23 Jul 2018 – 15 Aug 2018 | Human Drugs | 483 | On file |
| 23 Jul 2018 – 8 Aug 2018 | Human Drugs | 483 | On file |
| 12 Feb 2018 – 15 Feb 2018 | Human Drugs | Clean | |
| 16 Oct 2017 – 27 Oct 2017 | Human Drugs | 483 | On file |
| 16 May 2016 – 8 Jun 2016 | Medical Devices & Rad Health | WL | On file |
| 23 Mar 2015 – 3 Apr 2015 | Human Drugs | 483 | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
17 Jan 2025
21 CFR 211.110(a)
Control procedures to monitor and validate performance
Cited by Chad W Rice, Jacob G Lutz, Monica E Murie, Eric D Bowles
17 Jan 2025
21 CFR 211.113(b)
Procedures for sterile drug products
Cited by Chad W Rice, Jacob G Lutz, Monica E Murie, Eric D Bowles
17 Jan 2025
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Chad W Rice, Jacob G Lutz, Monica E Murie, Eric D Bowles
17 Jan 2020
21 CFR 211.100(b)
SOPs not followed / documented
Cited by Jazmine N Still, Simone E Pitts, Scott A Golladay
17 Jan 2020
21 CFR 211.110(a)
Control procedures to monitor and validate performance
Cited by Jazmine N Still, Simone E Pitts, Scott A Golladay
Investigators
FDA investigators tied to this site in the record.
Robert J Ham3 insp.
Eric M Mueller3 insp.
Richard L Rutherford3 insp.
Rita K Kabaso2 insp.
Michele Perry-Williams2 insp.
Michele L Obert2 insp.
Tara L Breckenridge2 insp.
Wayne E Seifert1 insp.
Doan N Singh1 insp.
Chad W Rice1 insp.
Jacob G Lutz1 insp.
Monica E Murie1 insp.
Eric D Bowles1 insp.
Lewis K Antwi1 insp.
Alan L Truong1 insp.
Matthew M Schuckmann1 insp.
Damaris Y Hernandez1 insp.
Susan M Jackson1 insp.
Christine Harman1 insp.
Hector A Carrero1 insp.
Jazmine N Still1 insp.
Simone E Pitts1 insp.
Scott A Golladay1 insp.
Steven D Kehoe1 insp.
Eric M Padgett1 insp.
Sarah E Rhoades1 insp.
Shafiq Ahadi1 insp.
Brett R Havranek1 insp.
Carl A Huffman1 insp.
Monica M Mcclure1 insp.
Ralph H Vocque1 insp.
Cody D Rickman1 insp.
Ashley A Mutawakkil1 insp.
Tara L Greene1 insp.
Janet B Abt1 insp.
Shirley J Berryman1 insp.
Brittany D Terhar1 insp.
Matthew R Sleeter1 insp.
Anthony Bucks1 insp.
Joseph R Lambert1 insp.
Michele Perry Williams1 insp.
Andrew A Hoopes1 insp.
David J Eide1 insp.
Gwyn G Dickinson1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.46(c) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.110(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(b)(4) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.184(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.186(b)(9) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.80(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(d)(3) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Hospira, Inc.'s 17 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat